TL;DR
The development and validation of an in situ hybridization (ISH) custom BaseScope assay for the detection of the FOXL2 C134W mutation represents a reasonable alternative to sequencing, is quicker and less expensive, and is more easily incorporated into many pathology laboratories.
AI-generated by Semantic Scholar